Promoters of SMT—the Kotadia family— plan to keep a minority stake after the transaction that would see other shareholders ...

Mumbai: Pharmaceutical giants Cipla and Alkem Laboratories are in the final stages of a bidding war to acquire a controlling ...

Mumbai: Alkem Laboratories Ltd. has entered into a licensing agreement with US-based Sonnet BioTherapeutics Holdings, Inc to ...

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...

This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.

Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...

The PE firms are up against Dr Reddy's, which has an alliance with Novartis for marketing some of its off-patent products and ...

新泽西州普林斯顿 - 临床阶段生物技术公司Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN)已与Alkem Laboratories Limited签订许可协议，在印度开发和商业化SON-080。SON-080是一种重组人白细胞介素-6(rhIL-6)，旨在治疗糖尿病周围神经病变(DPN)、化疗引起的神经病变(CIPN)和自主神经病变。 根据协议 ...

Shares of BSE, Voltas, Adani Energy Solutions, Alkem Laboratories, Oberoi Realty, and Kalyan Jewellers may be included in the ...

India's largest stent manufacturer, Sahajanand Medical Technologies is also reportedly exploring a public listing on the domestic market ...

(RTTNews) - Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem Laboratories Ltd. for the research, development ...